Financial Performance

Winthrop Wealth's repeat 'Best Workplace' award isn't just a plaque. It's a blueprint for how strategic cultural investment builds a competitive moat.

Symplicity joins Ellucian's Partner Network, aiming to give CIOs a 360-degree student view and end the chaos of fragmented tech stacks.

We trust our refrigerators to keep food fresh, but their dry air costs the average family $1,600 in wasted produce. A new technology aims to fix this.

Point Wild's acquisition of Funambol signals a major push beyond traditional security, targeting data ownership and a deep integration into the global telco market.

A new partnership between Pioneer Energy and Rolfson Oil is slashing costs and emissions by turning wasted wellhead gas into valuable fuel for frac fleets.

Inipharm's INI-822 study leverages genetic insights for an oral MASH therapy, challenging injectable rivals and offering new hope for high-risk patients.

Zacks Investment Management launches two new income ETFs, ZINC and PRIZ, targeting an 8% yield. But can their 'simple', research-driven approach deliver?

Darigold's partnership with Actus Nutrition isn't a retreat, but a strategic masterstroke redefining the value of milk in a high-tech protein market.

One year after its US launch, Pictor Holdings is gaining traction with a platform that makes complex disease testing fast, cheap, and accessible. But can its unique business model truly scale?

TappAlpha's TSPY fund gets S&P 500® branding and a cost cut. We look past the polish to see what the changes mean for your portfolio's bottom line.

Beyond a single deal, LTC is trading its stable landlord model for a high-growth operator strategy, betting hundreds of millions on the future of senior care.

Microchip's new low-latency retimers aim to solve the data traffic jams crippling AI data centers, shifting focus from raw compute to high-speed connectivity.

The FDA just granted Orphan Drug status to a promising ALS therapy. It's a beacon of hope for patients and a masterclass in biotech strategy.

An alliance between MyCreds and ORCID is more than a tech upgrade; it's a strategic move to build a national moat of trust for Canada's global research standing.

As the old AYR Wellness liquidates, its key assets are reborn under creditor control. A forensic look at the deal, the debt, and what it signals for the industry.

A landmark partnership between Livium and Garage Composites fuses advanced data analytics with peer collaboration, setting a new standard for dealer profitability.

Brillio’s appointment of a top AI mind signals a crucial shift. For banks, the era of AI pilots is over; the race to production has begun.

NXG NextGen Infrastructure Fund boosts its dividend by 11.1%, but it's all 'return of capital'. We deconstruct what this means for income investors.

The Buckle's latest dividend isn't just a shareholder payout; it's a signal of strategic resilience in a tough retail market. Here's the deeper story.

A new manufacturing deal sees Bluejay Diagnostics bet on U.S. resilience. It's a strategic retreat from global risk for a firm facing a long regulatory road.